baber/WOPTO huggingface dataset:
Patent DE-69105806-D1 (DE)
Inventor: CHAUVEAU JEAN-PIERRE
IPC: G02C7/02
Filed: 1991-04-22
Granted: 1995-01-26
Abstract: This relates to a progressive ophthalmic lens whose front face (11A) for example comprises, continuously, on the one hand, a central zone (14) which, having a progressively variable curvature along at least a portion of at least one meridian, is the optically useful zone of it and, on the other hand, surrounding this central zone (14), a peripheral connection zone (15) connecting the central zone tangentially. 
<??>According to the invention, the optically useful central zone (14) of this front face (11A) is delimited by a closed curve which, in projection onto a plane perpendicular to the geometrical axis of the assembly, has everywhere an oval shape and the radius of curvature of the radial section of its peripheral connection zone (15) varies circumferentially in value and/or in sign, such that around its peripheral edge (13) the lens is of equal thickness everywhere. 
<??>Application for obtaining progressive ophthalmic lenses which are easier to produce, more aesthetic and lighter. 
<IMAGE>
Patent DE-69106843-D1 (DE)
Inventor: BOWKETT TREVOR GEORGE
IPC: B29C35/16
Filed: 1991-11-11
Granted: 1995-03-02
Abstract: A method of and apparatus for shaping thermoplastic tube (1) by external formers (5,6,7,8) uses pulsed emission of short wave infra-red radiation (33) to soften the thermoplastic material with the tube (1) held in the required configuration on the formers (5,6,7,8) followed by air cooling (33) to harden the thermoplastic material and retain the required configuration. A jig (3) for supporting the tube (1) in the desired configuration comprises a base table (4) on which the formers (5,6,7,8) are adjustably mounted for altering the desired configuration. <IMAGE>
Patent DE-69111642-D1 (DE)
Inventor: WOODRUFF GEOFFREY NEIL
IPC: C07C229/28
Filed: 1991-01-02
Granted: 1995-09-07
Abstract: The instant invention is novel uses of known cyclic amino acids. Such compounds as gabapentin are used for treating neurodegenerative disorders, perinatal asphyxia, status epilepticus, Alzheimer's, Huntington's, Parkinson's, and Amyotrophic Lateral Sclerosis.
Patent DE-69115917-D1 (DE)
Inventor: SEELIG GAIL
IPC: C07K16/24
Filed: 1991-09-25
Granted: 1996-02-08
Abstract: PCT No. PCT/US91/06771 Sec. 371 Date Mar. 19, 1993 Sec. 102(e) Date Mar. 19, 1993 PCT Filed Sep. 25, 1991 PCT Pub. No. WO92/06115 PCT Pub. Date Apr. 16, 1992.Novel synthetic polypeptides having amino acid sequences corresponding to the sequence of one or more specific regions of human gamma interferon are provided by this invention. These polypeptides specifically inhibit the binding of human gamma interferon to cellular receptors and the biological activity of such interferon. Antibody antagonists of the binding of human gamma interferon to cellular receptors based Upon the use of the polypeptides as antigens are also provided. Some of these antagonists bind to specific regions of gamma interferon which are believed to be involved in interactions between the intefferon and its receptors. Other antibody antagonists are anti-idiotypic antibodies which appear to compete directly with gamma interferon for binding to the cellular receptors. Also provided are methods for the use of the polypeptides and antibodies as inhibitors of the binding of gamma interferon to its cellular receptors.
Patent DE-69119544-D1 (DE)
Inventor: BRETAUDEAU DOMINIQUE
IPC: C11D3/12
Filed: 1991-10-31
Granted: 1996-06-20
Abstract: Process for continuous preparation of crystalline zeolite 4A by direct mixing in an unstirred reactor of aqueous solutions of sodium silicate and aluminate, bringing the hydrogel formed into contact with a base stock of sodium aluminate, crystallisation, washing, filtration and optionally drying.
Patent DE-69122605-D1 (DE)
Inventor: SUZUKI TOSHIMITSU
IPC: A61K31/415
Filed: 1991-01-24
Granted: 1996-11-14
Abstract: A 2-nitroimidazole derivative represented by general formula (I) and a radiosensitizer containing the same as the active ingredient, wherein R1, R2 and R3 may be the same or different from each other and each represents hydrogen or acyl. This compound (I) has such an excellent radiosensitizing effect and high safety that the radiosensitizer containing the same is remarkably useful in the radiotherapy of cancers. <CHEM>
Patent DE-69132146-D1 (DE)
Inventor: GARDNER JR
IPC: A61L27/18
Filed: 1991-08-16
Granted: 2000-05-31
Abstract: A hearing protective earplug which permits alternative push-in and roll-down modes of insertion. The earplug (100) includes a soft, smoothly contoured, resilient, homogeneous viscoelastic polymeric foam main body element (1) adapted in size and shape to be inserted into a human ear canal, and an elongate stem (10) extending rearwardly and outwardly therefrom. In one embodiment, the main body element (1) transitions into a terminal flared end portion (12) lying at the outboard end. The stem (10) is typically of such length that the free end (9) thereof extends beyond the body element (1).
Patent DE-69211105-D1 (DE)
Inventor: BAGGIOLI GIUSEPPE
IPC: B62D5/12
Filed: 1992-12-04
Granted: 1996-07-04
Abstract: A hydraulic actuator, in particular for motor-vehicle power steerings, comprises a cylindrical tubular body (7) provided with closing elements (8) at the respective ends, and housing a piston (9) carrying a drive rod (10) slidably and sealingly passing through the closing elements (8). The tubular body (7) exhibits a tubular core (21) in the form of an extruded section having the respective ends hermetically engaged by the closing elements (8) and carrying connection seatings (26, 27) for sealingly engaging hydraulic coupling elements (17, 18) opening into respective pressurisation chambers (15, 16) defined within the cylindrical tubular body (7) by the piston (9). The tubular section (21) is coated with a die-cast skirt (22) carrying attachment tailpieces (7a) for fastening of the actuator (1) to a bearing structure. <IMAGE>
Patent DE-69219918-D1 (DE)
Inventor: LUKE JOHN ANTHONY
IPC: A24D1/00
Filed: 1992-01-28
Granted: 1997-07-03
Abstract: This invention provides a smoking article (1) having reduced sidestream smoke in the inter-puff period. A smoking article (1) according to the invention may comprise segments of a high level of tobacco-containing material (5) interconnected by segments of low level of tobacco-containing material(6) which are capable of maintaining smoulder in the inter-puff period and re-igniting the segments of a high level of tobacco-containing material(5) in the puff period. Alternatively, a smoking article according to another aspect of the invention may comprise a lengthwise, axially extending, tobacco-containing fuse portion (46) which sustains smoulder in the inter-puff period when surrounding tobacco material (45) is substantially extinguished and which re-ignites the extinguished material on puffing of the smoking article(1). <IMAGE>
Patent DE-69229114-D1 (DE)
Inventor: GERSTER JOHN
IPC: C07D/
Filed: 1992-02-20
Granted: 1999-06-10
Abstract: Intermediates for preparing 1-substituted, 2-substituted 1H-imidazo Ä4,5-cÜ-quinolin-4-amines of formula (I) are provided where X is selected from the group consisting of alkoxy, alkoxyalkyl, haloalkyl, hydroxyalkyl, alkylamido, amino or substituted amino wherein the substituent is alkyl, hydroxyalkyl, azido, chloro, hydroxy, 1-morpholino, 1-pyrrolidino, and alkylthio. The compounds of formula (I) function as antiviral agents, they induce biosynthesis of interferon, and they inhibit tumor formation in animal models. <CHEM>
Patent DE-69232323-D1 (DE)
Inventor: SHIOKAWA YOUICHI
IPC: A61P43/00
Filed: 1992-01-28
Granted: 2002-02-07
Abstract: A pharmaceutical composition for the prevention and/or the treatment of pancreatitis and/or ulcer which comprises, as an active ingredient, an adenosine antagonist or a pharmaceutically acceptable salt thereof in admixture with a pharmaceutically acceptable carrier or excipient.
Patent DE-69301499-D1 (DE)
Inventor: PALIARD MAURICE
IPC: C04B7/44
Filed: 1993-05-27
Granted: 1996-03-21
Abstract: Plant and process for precalcining any mineral matters. This plant comprises essentially a precalciner (2) consisting of a combustion chamber (20) communicating via a sleeve (21) with a reaction chamber (22) itself communicating via a conduit (24) with a separating cyclone (25), the reaction chamber (22) being fed with fumes (11) originating from a firing oven, and three conduits (27, 28, 31) feeding the combustion chamber (20), a volute (29) in the region of a burner (30) and the conduit (24), respectively, with hot air originating from a cooler. This plant makes it possible in particular to manufacture cement clinker while considerably minimising the emission of nitrogen oxides. <IMAGE>
Patent DE-69304065-D1 (DE)
Inventor: SKIBA MOHAMED
IPC: A61K9/51
Filed: 1993-06-16
Granted: 1996-09-19
Abstract: PCT No. PCT/FR93/00594 Sec. 371 Date Mar. 8, 1995 Sec. 102(e) Date Mar. 8, 1995 PCT Filed Jun. 16, 1993 PCT Pub. No. WO93/25195 PCT Pub. Date Dec. 23, 1993A nanoparticulate system prepared by: 1) preparing a liquid phase essentially consisting of a solution of cyclodextrin modified by acyl groups in an organic solvent or solvent mixture, an active molecule being optionally added thereto; 2) preparing a second liquid phase essentially consisting of water or an aqueous mixture optionally containing one or more surfactants, and optionally having an active molecule added thereto; and 3) gently stirring one of the liquid phases resulting from 1) or 2) into the other in order to obtain, almost instantaneously, a colloidal solution of modified cyclodextrin nanospheres. If required, all or part of the solvent and all or part of the water may be removed. The system may be used as a carrier for pharmaceuticals, cosmetics, chemicals, etc.
Patent DE-69310312-D1 (DE)
Inventor: VANGOMPEL PAUL THEODORE
IPC: A61F13/15
Filed: 1993-09-29
Granted: 1997-06-05
Abstract: An elongated sanitary napkin (10) has deflectable longitudinal side edges (34,36) formed by an edge or peripheral seal (28) along the opposite sides of an absorbent (18). A garment attachment panel (14,16) is secured to the underside of each side edge. A fixed portion (50) of the panel (14) is bonded flat against the side edge so that a free portion (52) of the panel (14), extending from the fixed portion (50), is directed inward and downward. During use, the panels (14,16) are fastened together beneath an undergarment crotch portion by hook (58) and loop (60) type fastener. Fastener (58,60) and panels (14,16) are sized so that when fastened the panels (14,16) exert a pull on the side edges, controlling their deflection and, for example, preventing them from folding in over the absorbent (18). The garment attachment panels (14,16) confine the undergarment crotch portion under the absorbent (18) so that, for example, an elasticized edge of the crotch portion is prevented from pulling up and onto the absorbent (18). <IMAGE>
Patent DE-69319120-D1 (DE)
Inventor: ABELE MANLIO
IPC: H01F7/02
Filed: 1993-07-27
Granted: 1998-07-16
Abstract: A high field strength permanent magnet has a plurality of layers, with at least two of the layers being formed of materials of different remanence. The remanence of the material of each layer is no greater than that of the layers thereunder, and is preferably less than the remanence of all underlying layers. The inner layer may be formed of a magnetic structure in which all or part of a basic yoke has been replaced by a shunt of active material. Such a shunt may alternatively be employed in a single layer magnetic structure.
Patent DE-69332480-D1 (DE)
Inventor: SONDERMEIJER PAULUS JACOBUS AN
IPC: A61K39/245
Filed: 1993-07-23
Granted: 2002-12-19
Abstract: The present invention is concerned with a Feline Herpesvirus (FHV) mutant comprising a heterologous gene or foreign DNA inserted into a section of the FHV genome. The invention also relates to a vector vaccine comprising a recombinant FHV mutant which expresses a heterologous polypeptide derived from a feline pathogen and a pharmaceutically acceptable carrier and induces an immune response in an inoculated host against both FHV and the feline pathogen.
Patent DE-69401727-D1 (DE)
Inventor: KARLSSON PETER
IPC: A61B5/308
Filed: 1994-06-22
Granted: 1997-03-27
Abstract: A device for eliminating ringings in filtered ECG-signals comprises an A/D-converter (10) for converting analog input signals into a series of digital values and a filter unit (14, 16) connected to the output of the A/D-converter. The filter unit comprises a recursive IIR-filter (14) and a subsequent allpass-filter (16) with a phase shift which is equal to twice the phase shift of the IIR-filter. The allpass-filtration is performed time-reversed in relation to the IIR-filtration. In a method for producing an allpass-filter (16) with a phase shift which is equal to twice the phase shift of an IIR-filter (14) the zero points of which are situated on the unity circle in the Z-plane, which allpass-filter is suitable for use in the device according to the invention, the zero points of the IIR-filter are replaced by new zero points obtained by reflecting the poles of the filter in the unity circle in the Z-plane. <IMAGE>
Patent DE-69426159-D1 (DE)
Inventor: PHELPS PATRICIA V
IPC: A61P31/04
Filed: 1994-08-29
Granted: 2000-11-23
Abstract: A method of introducing a substance (14) into a bird egg through the shell thereof comprises the steps of applying a seal (10) to the exterior of the shell, inserting an injection device (11) through the seal (10) and into the egg, injecting the substance (14) through the injection device (11) and into the interior of the egg, and withdrawing the injection device (11) from the egg through the seal (10). The method is particularly preferred for injecting substances into the albumin during the first quarter of incubation through the bottom of the egg when the small end (8) of the egg is oriented downward to prevent the introduction of air bubbles through the opening formed in the shell by the injection device (11). <IMAGE>
Patent DE-69501156-D1 (DE)
Inventor: HUME SHAUN ALEXANDER
IPC: E03B1/04
Filed: 1995-03-17
Granted: 1998-01-15
Abstract: Water recycling apparatus (22) including a header tank (24) with a recycled water inlet (40) for supplying recycled water to the tank (24), a recycled water outlet (46) and tank water-level dependent control means for controlling a back-up supply of fresh water to the tank via a fresh water supply (54) which maintains the recycled water outlet (46) submerged even when recycled water is not available. An invert level (82) of an unrestricted spillway overflow (50) is situated below an outlet aperture (56) of the fresh water supply (54) to avoid the possibility of contamination of the fresh water supply. The overflow may be constituted by a slot in a side of the tank (24) or a region of tank wall which is lower than other regions.
Patent DE-69507148-D1 (DE)
Inventor: HAUDEBERT LIONEL
IPC: G12B17/02
Filed: 1995-08-04
Granted: 1999-02-18
Abstract: PCT No. PCT/FR95/01052 Sec. 371 Date Jun. 9, 1997 Sec. 102(e) Date Jun. 9, 1997 PCT Filed Aug. 4, 1995 PCT Pub. No. WO96/06480 PCT Pub. Date Feb. 29, 1996A protection device (70) for providing a drive system (60) for imparting rotary drive between two mechanical members (28, 44) about an axis by magnetic coupling with protection from an external magnetic field, said drive system including at least two axially magnetized elements (62a, 62b, 64a, 64b) each secured to at least one of said mechanical members and designed to interact with one another, said magnetized elements being axially offset, said protection device comprising two parts (72, 74; 92, 94; 96, 98) of magnetic material surrounding said drive system, each of said parts having a minimum radial extent greater than the radial extent of said magnetized elements, the protection device being characterized in that the two parts (72, 74; 92, 94; 96, 98) of magnetic material leave between them an axial space (76) so as to reduce the gradient of the external magnetic field at the drive system, and have an axial extent such that they encompass said drive system axially.
Patent DE-69512065-D1 (DE)
Inventor: PERSAUD KRISHNA
IPC: G01N27/12
Filed: 1995-06-20
Granted: 1999-10-14
Abstract: A gas sensor comprising a pair of electrodes. The gas sensor includes one or more semiconducting organic polymers deposited between the pair of electrodes in such a manner as to effect a semiconducting electrical connection therebetween. The gas sensor also includes a device for applying an electric signal across the electrodes and a detector for detecting a chosen electrical property across the electrodes in the presence of a gas. At least one of the semiconducting organic polymers is polymerized from a monomer comprising a five membered heterocyclic aromatic ring with substituent groups at the 2 and 5 positions.
Patent DE-69517201-D1 (DE)
Inventor: TAKASE AKIRA
IPC: C07C69/738
Filed: 1995-12-21
Granted: 2000-06-29
Abstract: A process for producing a compound of the formula (I): <CHEM> wherein R<1> and R<2> are the same or different and are hydrogen or alkyl, and R is hydrogen or alkyl, which comprises removing the protective group (P) of hydroxyl of a compound of the formula (II): <CHEM> wherein P is a protective group of hydroxyl,  SIMILAR  indicates an E-isomer, Z-isomer or a mixture thereof, and the other symbols are as defined above; and an intermediate for the production of the compound of the formula (I).
Patent DE-69518373-D1 (DE)
Inventor: CHENARD BERTRAND L
IPC: A61P25/30
Filed: 1995-09-07
Granted: 2000-09-21
Abstract: The present invention relates to novel compositions containing the serotonin selective re-uptake inhibitor (SSRI), preferably (1S-cis)4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthale namine, and an agonist or antagonist of the serotonin 1 (5-HT1) receptor and to the use of such compositions for treating or preventing a condition selected from mood disorders, including depression, seasonal affective disorders and dysthmia, anxiety disorders including generalized anxiety disorder and panic disorder; agoraphobia, avoidant personality disorder; social phobia; obsessive compulsive disorder; post-traumatic stress disorder; memory disorders including dementia, amnestic disorders and age-associated memory impairment; disorders of eating behavior, including anorexia nervosa and bulimia nervosa; obesity; cluster headache; migraine; pain; Alzheimer's disease; chronic paroxysmal hemicrania; headache associated with vascular disorders; Parkinson's disease, including dementia in Parkinson's disease, neuroleptic-induced parkinsonism and tardive dyskinesias; endocrine disorders such as hyperprolactinaemia; vasospasm (particularly in the cerebral vasculature); hypertension; disorders in the gastrointestinal tract where changes in motility and secretion are involved; sexual dysfunction, including premature ejaculation; and chemical dependencies.
Patent DE-69523851-D1 (DE)
Inventor: SASAKI HIROSHI
IPC: G06K9/00
Filed: 1995-08-31
Granted: 2001-12-20
Abstract: A code pattern of an information recording medium contains processing information necessary to editing data according to a restoration processing procedure for restoring multimedia information. The restoration processing procedure has a hierarchical structure of layers 1 to 5. The layer 5 has a file management function. The layer 4 has a function of collecting subset elements to create a subset and converting the same to create a data transfer unit (sector) which the layer 5 deals with. The layer 3 or lower layer has a function of reading the code pattern from the information recording medium, subjecting the code pattern to a preset restoration process and outputting the subset elements. <IMAGE>   <IMAGE>
Patent DE-69527978-D1 (DE)
Inventor: WOLF MIKAEL
IPC: G06F15/16
Filed: 1995-12-08
Granted: 2002-10-02
Abstract: PCT No. PCT/SE95/01480 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Dec. 8, 1995 PCT Pub. No. WO96/18148 PCT Pub. Date Jun. 13, 1996In a system for managing internal execution threads in a process, the execution threads are driven by process internal event messages. These messages are distributed to event receiving threads based upon distribution categories of event generating functions and performed only to event receiving threads which have interest in such internal messages and cause monitoring of the occurrency thereof. With each distribution category there is associated a number of event receiving threads, a number of first entities representing one or more monitorings for one event generating function to some event receiving thread, a number of second entities representing a monitoring for event generating functions of the distribution category, and a third entity for keeping track of all event receiving threads that have monitored the distribution category.
Patent DE-69528762-D1 (DE)
Inventor: FANG GERARD
IPC: A61K31/00
Filed: 1995-05-02
Granted: 2002-12-12
Abstract: The present invention relates to a method for preparing intermediates useful in the preparation of camptothecin and camptothecin-like compounds and to the intermediates used in this preparation. In particular, the invention provides a process for the preparation of a compound of formula II' <CHEM> wherein X is halogen, which comprises reacting a compound of formula III <CHEM>  with a compound of formula IX' <CHEM>
Patent DE-69531120-D1 (DE)
Inventor: DOBBINS BOB M
IPC: G07F5/18
Filed: 1995-09-15
Granted: 2003-07-24
Abstract: An automatic transaction system which enables payment in multiple currencies for the dispensing of a product or the providing of a service. In one embodiment, the automatic transaction system performs a conversion of payment deposited in currencies to credit amounts in the base currency to facilitate payment of any change due in denominations of the base currency. The conversion technique employed by one embodiment of the system translates the value of the denominations of a deposited second currency to a value in the base currency using an exchange rate. The translated value is then rounded down to the nearest multiple of an increment of the base currency accepted by the system. In other embodiment, the system performs conversion of deposited currencies to a reference currency while paying change in the base currency.  <IMAGE>
Patent DE-69532611-D1 (DE)
Inventor: GOLOVISTIKOV IVAN NIKOLAEVICH
IPC: C12N5/07
Filed: 1995-03-16
Granted: 2004-04-01
Abstract: The proposed means for treating autoimmune diseases with an immunodeficit of suppressor cells is trophoblastic beta-1 glycoprotein. The proposed method of treating autoimmune diseases involved the administration of an immunocorrective agent, specifically, trophoblastic beta-1 glycoprotein; indicators for the use of the said agent are obtained by testing of mononuclear cells for sensitivity to trophoblastic beta-1 glycoprotein.
Patent DE-69532817-D1 (DE)
Inventor: GIESE NEILL A
IPC: C07D231/38
Filed: 1995-11-09
Granted: 2004-05-06
Abstract: A method for selectively inhibiting a kinase is disclosed, which comprises contacting a composition containing a kinase with a compound of the formula: wherein: R1 is lower alkyl, lower hydrocarbyl, aryl lower alkyl, heteroaryl lower alkyl, 5- or 6-membered heterocyclic aromatic, polyaromatic, polyaromatic carbonyl, polyheteroaromatic or polyheteroaromatic carbonyl; R2 is lower alkyl, lower hydrocarbyl, aryl lower alkyl, heteroaryl lower alkyl, 5- or 6-membered heterocyclic aromatic, lower hydrocarboyl, 5- or 6-membered heterocyclic aromatic carbonyl, polyaromatic or polyheteroaromatic; R3 is H or lower alkyl; R5 is H, lower alkyl, lower hydrocarbyl, aryl lower alkyl, heteroaryl lower alkyl, 5- or 6-membered heterocyclic aromatic, halogen, or cyano; and R6 is H or lower hydrocarboyl.